Academic Journal
Q1Journal of Cardiovascular Translational Research
About Journal of Cardiovascular Translational Research
About Journal of Cardiovascular Translational Research
Journal of Cardiovascular Translational Research is a peer-reviewed scholarly journal published by 199 (United States). It focuses on Q1. Publication coverage spans 2008-2026.
Key indicators: ISSN 1937-5395, 1937-5387; H-index 68.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (68): Strong citation impact — 68 articles cited at least 68 times each, reflecting solid influence.
Publishing in Journal of Cardiovascular Translational Research
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Cardiovascular Translational Research?
1937-5395, 1937-5387.
Who publishes Journal of Cardiovascular Translational Research?
199.
What are Journal of Cardiovascular Translational Research's metrics?
H-index 68.
Where do I submit to Journal of Cardiovascular Translational Research?
Via the official website.
Is Journal of Cardiovascular Translational Research peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Cardiovascular Function and Risk Factors; Cardiac Valve Diseases and Treatments; Cardiac Imaging and Diagnostics; Cardiac Fibrosis and Remodeling; Tissue Engineering and Regenerative Medicine; Coronary Interventions and Diagnostics.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,390.00 USD; 3,290.00 EUR; 2,790.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
α7-nAChR Activation is Associated with Attenuation of Cardiac Fibrosis in Ischemic Cardiomyopathy via SIRT3-Dependent Modulation of EndMT
Ruilin He, Shujie Wu, Que Xu, Yifan Lin et al.
2026-12 · DOI: 10.1007/s12265-026-10857-6YAP and WWTR1/TAZ Connect Mechanotransduction and Mitochondrial Metabolism in Cardiac Hypertrophy and Ventricular Remodeling
Feihu Yu, Zuqiu Liu, Jimiao Qiu, Huashan Chen et al.
2026-12 · DOI: 10.1007/s12265-026-10858-5Higher Myocardial miR-1-3p, miR-30a-5p, miR-34a-5p, and Lower miR208a-3p Levels are Associated with Lower Age at the Time of Heart Transplantation
Vid Mirosevic, Tanja Blagus, Tomo Svagusa, Ana Livun et al.
2026-12 · DOI: 10.1007/s12265-026-10854-9Stacking Ensemble Learning for Diagnosing Acute Myocardial Infarction in Mice Using Plasma Raman Spectroscopy and Mass Spectrometry
Chunyan Duan, Jing Sun, Shijun Chen, Zhengshi Wang et al.
2026-12 · DOI: 10.1007/s12265-026-10856-7Deep Survival Modeling With Echocardiographic Myocardial Texture Radiomics for Prediction of Major Adverse Cardiovascular Events in Hypertrophic Cardiomyopathy
Guizi Liang, Jiangyu Han, Xiaolan Huang, Xing Chen et al.
2026-12 · DOI: 10.1007/s12265-026-10845-wDiagnostic Accuracy of Circulating MicroRNAs for Coronary Artery Disease: An Updated Systematic Review and Meta-analysis
Shankar Biswas, Yashasvi Srivastava, Ayman Hamadttu
2026-12 · DOI: 10.1007/s12265-026-10848-7Retraction Note: lncRNA HOTAIR Protects Myocardial Infarction Rat by Sponging miR-519d-3p
Dongying Zhang, Bingjian Wang, Min Ma, Kun Yu et al.
2026-12 · DOI: 10.1007/s12265-026-10850-zMetabolite-based Analysis of High-Risk Factors on Occurrence of AKI in Patients with Acute Myocardial Infarction
Yan Yao, Fei Liu, Jie Meng, JinJing Zhang et al.
2026-12 · DOI: 10.1007/s12265-026-10849-6RNA-Binding Proteins Regulate Cardiovascular Disease Progression Through Alternative Splicing and Alternative Polyadenylation
Zhaojunze Huang, Xianting Yang, Long Wang, Jiashun Huang et al.
2026-12 · DOI: 10.1007/s12265-026-10844-xSuppression of Calpain Attenuates Coxsackievirus B3-Induced Myocarditis by Regulating RIPK1/RIPK3/MLKL Pathway
Yuxi Liu, Yong Wang, Guijian Liu, Fei Yi et al.
2026-12 · DOI: 10.1007/s12265-026-10744-0Nesfatin-1 as a Cardiovascular-Metabolic-Immune Integrator: Insights from Cellular Cross-talk to Precision Medicine
Xinru Wang, Ruyi Du, Yuchen Wang, A Z M Fahim Siddique et al.
2026-12 · DOI: 10.1007/s12265-026-10830-3Next-Generation Bone Marrow Cell Therapies for Cardiac Repair: Integrating Gene Therapy and Bioengineering to Enhance Therapeutic Potency
Busra Cesur Ergun, Busra Cetin, Ozgur Dandin, Salih Sanlioglu et al.
2026-12 · DOI: 10.1007/s12265-026-10847-8Cross-cohort Generalization for Heart Disease Prediction with Explainable AI
Prosper Ughakpoteni, Yaseen Akhtar, Ahmad Chaddad, Sarah Alkhodair et al.
2026-12 · DOI: 10.1007/s12265-026-10842-zCardioMOD-Net: A Modal Decomposition–Neural Network Framework for Diagnosis and Prognosis of Heart Failure with Preserved Ejection Fraction from Echocardiography Cine Loops
Andrés Bell-Navas, Jesús Garicano-Mena, Antonella Ausiello, Soledad Le Clainche et al.
2026-12 · DOI: 10.1007/s12265-026-10832-1Mitochondrial Ferritin in Subclinical Anthracycline-Induced Cardiotoxicity in Humans: A Pilot Study
Giuseppe Pinto, Paolo Santambrogio, Sonia Maria Rosa Levi, Giulia Marchionni et al.
2026-12 · DOI: 10.1007/s12265-026-10846-9Author Response to ‘Persistent Proteomic Signatures in Takotsubo Syndrome: Methodological Considerations Regarding Reference Cohort Selection and Confounding’
Paul Marano, Jennifer E. Van Eyk, C. Noel Bairey Merz
2026-12 · DOI: 10.1007/s12265-026-10838-9Cardiac Macrophage-specific circHIPK2: a New Regulator of Post-infarction Inflammation and Cardiac Remodeling
Pengjie Tao, Yeting Zhang, Yuwen Chen, Stephan Erbe et al.
2026-12 · DOI: 10.1007/s12265-026-10836-xSelf-Nanoemulsifying Drug Delivery Systems for Cardiovascular Therapeutics: Formulation Strategies, Pharmacokinetic Enhancement and Precision-Oriented Translation
Rohit Sharma, Abhay Thakur, Rahul Sharma
2026-12 · DOI: 10.1007/s12265-026-10841-0The Role and Mechanism of Endothelial Progenitor Cell–Derived Extracellular Vesicles in Vascular Repair of Ischemic Heart Disease
Qiling Han, Xinmei Wang, Houjin Zhao
2026-12 · DOI: 10.1007/s12265-026-10822-3Collagen Prolyl 4-Hydroxylase: An Emerging Key Player in Cardiac Fibrosis
Wei Hua, Zai-Xin Yu, Li-Huang Zha
2026-12 · DOI: 10.1007/s12265-026-10843-yReviews
Community Reviews
Version History
October 9, 2026 at 10:21 pm
October 2, 2026